There is no company description available for Axcella Health Inc.
Industry, Sector and Symbol
Industry Biological products, except diagnostic
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone857-320-2200
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
EmployeesN/A
Next Earnings Date11/11/2019 (Estimated)
OptionableNot Optionable
Axcella Health (NASDAQ:AXLA) Frequently Asked Questions
What is Axcella Health's stock symbol?
Axcella Health trades on the NASDAQ under the ticker symbol "AXLA."
How were Axcella Health's earnings last quarter?
Axcella Health Inc (NASDAQ:AXLA) issued its quarterly earnings data on Monday, August, 12th. The company reported ($0.95) earnings per share for the quarter, missing the Zacks' consensus estimate of ($0.65) by $0.31. View Axcella Health's Earnings History.
When is Axcella Health's next earnings date?
What price target have analysts set for AXLA?
4 Wall Street analysts have issued twelve-month price targets for Axcella Health's shares. Their predictions range from $20.00 to $25.00. On average, they anticipate Axcella Health's share price to reach $22.00 in the next year. This suggests a possible upside of 243.8% from the stock's current price. View Analyst Price Targets for Axcella Health.
What is the consensus analysts' recommendation for Axcella Health?
4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Axcella Health in the last year. There are currently 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Axcella Health.
Has Axcella Health been receiving favorable news coverage?
Media coverage about AXLA stock has been trending negative this week, according to InfoTrie Sentiment. InfoTrie scores the sentiment of news coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Axcella Health earned a media sentiment score of -2.9 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an effect on the stock's share price in the next several days. View News Stories for Axcella Health.
Who are some of Axcella Health's key competitors?
Some companies that are related to Axcella Health include DBV TECHNOLOGIE/S (DBVT), AVITA MED LTD/S (AVMXY), Autolus Therapeutics (AUTL), Translate Bio (TBIO), Cellectis (CLLS), Precision BioSciences (DTIL), Avrobio (AVRO), Solid Biosciences (SLDB), Tcr2 Therapeutics (TCRR), Agenus (AGEN), Harpoon Therapeutics (HARP), Prevail Therapeutics (PRVL), Replimune Group (REPL), Adverum Biotechnologies (ADVM) and Scholar Rock (SRRK).
What other stocks do shareholders of Axcella Health own?
When did Axcella Health IPO?
(AXLA) raised $76 million in an initial public offering (IPO) on Thursday, May 9th 2019. The company issued 3,600,000 shares at $20.00-$22.00 per share. Goldman Sachs, J.P. Morgan and SVB Leerink acted as the underwriters for the IPO.
When does Axcella Health's lock-up period expire?
Axcella Health's lock-up period expires on Tuesday, November 5th. Axcella Health had issued 3,571,428 shares in its public offering on May 9th. The total size of the offering was $71,428,560 based on an initial share price of $20.00. After the expiration of Axcella Health's lock-up period, major shareholders and company insiders will be able to sell their shares of the company.
Who are Axcella Health's major shareholders?
Axcella Health's stock is owned by many different of retail and institutional investors. Top institutional shareholders include Harbourvest Partners LLC (5.33%), Artal Group S.A. (1.69%), BlackRock Inc. (0.31%), Vanguard Group Inc. (0.23%), Tower Research Capital LLC TRC (0.06%) and KCL Capital L.P. (0.04%). Company insiders that own Axcella Health stock include D Clay Bretches, David R Epstein and Ventures Fund Iv LP Flagship. View Institutional Ownership Trends for Axcella Health.
Which major investors are buying Axcella Health stock?
AXLA stock was purchased by a variety of institutional investors in the last quarter, including Harbourvest Partners LLC, Artal Group S.A., BlackRock Inc., Vanguard Group Inc., Tower Research Capital LLC TRC , KCL Capital L.P., Northern Trust Corp and Morgan Stanley. Company insiders that have bought Axcella Health stock in the last two years include D Clay Bretches, David R Epstein and Ventures Fund Iv LP Flagship. View Insider Buying and Selling for Axcella Health.
How do I buy shares of Axcella Health?
Shares of AXLA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Axcella Health's stock price today?
One share of AXLA stock can currently be purchased for approximately $6.40.
How big of a company is Axcella Health?
What is Axcella Health's official website?
How can I contact Axcella Health?
Axcella Health's mailing address is 840 MEMORIAL DRIVE, CAMBRIDGE MA, 02139. The company can be reached via phone at 857-320-2200.
MarketBeat Community Rating for Axcella Health (NASDAQ AXLA)
MarketBeat's community ratings are surveys of what our community members think about Axcella Health and other stocks. Vote "Outperform" if you believe AXLA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AXLA will underperform the S&P 500 over the long term. You may vote once every thirty days.
